COYA
Price
$6.27
Change
-$0.11 (-1.72%)
Updated
Sep 5 closing price
Capitalization
104.87M
60 days until earnings call
KNSA
Price
$35.71
Change
+$0.20 (+0.56%)
Updated
Sep 5 closing price
Capitalization
2.65B
59 days until earnings call
Interact to see
Advertisement

COYA vs KNSA

Header iconCOYA vs KNSA Comparison
Open Charts COYA vs KNSABanner chart's image
Coya Therapeutics
Price$6.27
Change-$0.11 (-1.72%)
Volume$214.65K
Capitalization104.87M
Kiniksa Pharmaceuticals International
Price$35.71
Change+$0.20 (+0.56%)
Volume$328.3K
Capitalization2.65B
COYA vs KNSA Comparison Chart in %
Loading...
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COYA vs. KNSA commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COYA is a Hold and KNSA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (COYA: $6.27 vs. KNSA: $35.71)
Brand notoriety: COYA and KNSA are both not notable
COYA represents the Biotechnology, while KNSA is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: COYA: 273% vs. KNSA: 56%
Market capitalization -- COYA: $104.87M vs. KNSA: $2.65B
COYA [@Biotechnology] is valued at $104.87M. KNSA’s [@Pharmaceuticals: Generic] market capitalization is $2.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COYA’s FA Score shows that 0 FA rating(s) are green whileKNSA’s FA Score has 1 green FA rating(s).

  • COYA’s FA Score: 0 green, 5 red.
  • KNSA’s FA Score: 1 green, 4 red.
According to our system of comparison, KNSA is a better buy in the long-term than COYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COYA’s TA Score shows that 4 TA indicator(s) are bullish while KNSA’s TA Score has 3 bullish TA indicator(s).

  • COYA’s TA Score: 4 bullish, 5 bearish.
  • KNSA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both COYA and KNSA are a bad buy in the short-term.

Price Growth

COYA (@Biotechnology) experienced а -4.42% price change this week, while KNSA (@Pharmaceuticals: Generic) price change was +6.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

COYA is expected to report earnings on Nov 05, 2025.

KNSA is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNSA($2.65B) has a higher market cap than COYA($105M). KNSA YTD gains are higher at: 80.536 vs. COYA (9.424). KNSA has higher annual earnings (EBITDA): 5.98M vs. COYA (-22.59M). KNSA has more cash in the bank: 308M vs. COYA (29.8M). KNSA has higher revenues than COYA: KNSA (529M) vs COYA (423K).
COYAKNSACOYA / KNSA
Capitalization105M2.65B4%
EBITDA-22.59M5.98M-378%
Gain YTD9.42480.53612%
P/E RatioN/A714.20-
Revenue423K529M0%
Total Cash29.8M308M10%
Total DebtN/A9.77M-
FUNDAMENTALS RATINGS
KNSA: Fundamental Ratings
KNSA
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
45
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
32
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COYAKNSA
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 16 days ago
89%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 9 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
COYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSRKX20.00N/A
N/A
Goldman Sachs International Eq Inc R
RTRRX8.36N/A
N/A
Royce Small-Cap Total Return R
IBGIX20.37N/A
N/A
VY® Baron Growth I
GFSIX19.94N/A
N/A
Gabelli Global Financial Services I
PRDGX83.85-0.42
-0.50%
T. Rowe Price Dividend Growth

COYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, COYA has been loosely correlated with KNSA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if COYA jumps, then KNSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COYA
1D Price
Change %
COYA100%
-1.72%
KNSA - COYA
42%
Loosely correlated
+0.56%
GANX - COYA
37%
Loosely correlated
+1.15%
CRNX - COYA
34%
Loosely correlated
+3.97%
EYPT - COYA
33%
Loosely correlated
+17.93%
ZBIO - COYA
32%
Poorly correlated
+20.79%
More

KNSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with COYA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+0.56%
COYA - KNSA
39%
Loosely correlated
-1.72%
JBIO - KNSA
37%
Loosely correlated
-0.13%
SNDX - KNSA
36%
Loosely correlated
+5.25%
CPRX - KNSA
35%
Loosely correlated
+2.47%
ATXS - KNSA
35%
Loosely correlated
+7.43%
More